Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 10/20 | 0.72 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | PLAU | P00749 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.54 |
| ▸ | MEN1 | O00255 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.50 |
| ▸ | TP53 | P04637 | 2/20 | 0.50 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL307838 | 0.91 | ROCK2 (0.81) | ROCK2CYP3A4PLAUCYP2C19 | |
| SCHEMBL307678 | 0.85 | ROCK2 (0.67) | ROCK2CYP3A4PLAUCYP2C19MEN1 | |
| SCHEMBL307307 | 0.85 | ROCK2 (0.86) | ROCK2CYP3A4CYP2C19MEN1KMT2A | |
| SCHEMBL7242305 | 0.85 | PLAU (0.62) | ROCK2PLAUMEN1KMT2ATP53 | |
| SCHEMBL10159840 | 0.84 | ROCK2 (1.00) | ROCK2CYP3A4CYP2C19 | |
| SCHEMBL10159692 | 0.84 | ROCK2 (1.00) | ROCK2CYP3A4PLAUCYP2C19 | |
| SCHEMBL10160403 | 0.84 | ROCK2 (0.65) | ROCK2CYP3A4PLAUCYP2C19MEN1 | |
| SCHEMBL15651634 | 0.82 | ROCK2 (0.56) | ROCK2CYP3A4CYP2C19MEN1KMT2A | |
| SCHEMBL8546973 | 0.81 | MEN1 (0.53) | ROCK2CYP3A4PLAUMEN1KMT2A | |
| SCHEMBL7234090 | 0.80 | NPC1 (0.65) | PLAUMEN1KMT2ATP53FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2114869-B1 | RHO KINASE INHIBITORS | BOEHRINGER INGELHEIM INT (DE) | 2014-07-23 | — | — | EP | claimed |